Modulation of the GABAergic pathway for the treatment of fragile X syndrome

Modulation of the GABAergic pathway for the treatment of fragile X syndrome

Reymundo Lozano,1,2 Emma B Hare,1,2 Randi J Hagerman1,2 1MIND Institute, 2Department of Pediatrics, UC Davis Medical Center, Sacramento, CA, USA Abstract: Fragile X syndrome (FXS) is the most common genetic cause of intellectual disability and the most common single-gene cause of autism. It is caus...

Full description

Bibliographic Details
Main Authors: Lozano R, Hare EB, Hagerman RJ
Format: Article
Language:English
Published: Dove Medical Press 2014-09-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/modulation-of-the-gabaergic-pathway-for-the-treatment-of-fragile-x-syn-peer-reviewed-article-NDT

Internet

http://www.dovepress.com/modulation-of-the-gabaergic-pathway-for-the-treatment-of-fragile-x-syn-peer-reviewed-article-NDT

Similar Items